This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
FDG-PET/CT provides functional insights by detecting metabolic changes before structural alterations, making it valuable for therapy response monitoring, but it has limitations in visualizing metabolically silent bone metastases, according to Masperi and Girlando. Scans were conducted using two CT systems (Somatom go.Top from Siemens).
PET/CT imaging with a new radiotracer (F-18 PSMA-1007) is superior to MRI prior to surgery in men with intermediate-risk and high-risk prostate cancer, according to a study published on July 1 in JAMA Oncology. In this phase II clinical trial, the researchers sought to evaluate the approach further. The full study is available here.
The finding is from a phase I/II clinical trial in the U.S. In the trial, 30 patients with recurrent disease or metastatic prostate cancer underwent baseline conventional imaging (CT, MRI, or bonescan) and whole-body Ga-68 PSMA-R2 PET/CT between 20 minutes and four hours after injection.
Imagine going in for a diagnostic MRIscan and coming out with a progressive, irreversible, and potentially fatal disease. Last week, attorneys for a Cleveland man announced they had filed suit against a gadolinium manufacturer, claiming that he developed NSF from an injection of gadolinium MRI contrast. 356: 9234, pp.
Take Home Points Clinical presentation is very nonspecific; evaluate all patients presenting with back pain for infectious risk factors. MRI is key to diagnosis, obtain this imaging in all patients who raise clinical suspicion Patients with hemodynamic instability and neurologic compromise warrant empiric antibiotics.
Bonescan shows diffuse uptake in the markedly enlarged right breast secondary to increased blood pool activity and impaired washout. Discussion: 63-year-old woman presented to a clinic with a one month history of progressively enlarging right breast with redness and tenderness. Mammogram CC view.
It measures the heart’s ability to respond to external stress, but in a controlled clinical environment. MUGA Scan (Heart Ventricles) The MUGA (multigated acquisition) scan evaluates the function of the heart and measures how well the heart pumps blood with each heartbeat.
The findings suggest a better alternative to "conventional" imaging modalities such as CT alone, MRI, or bonescans for tracking prostate cancer in this particular patient population, wrote a team led by Adrien Holzgreve, MD, of the University of California, Los Angeles. The full study can be found here.
We organize all of the trending information in your field so you don't have to. Join 5,000 users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content